News & Events ESMO 2024 in Barcelona Show details All news & events STUDY MAY REVOLUTIONISE GLIOMA DIAGNOSIS Show details All news & events ESMO 2023 – Dr. Crook presents together with Datar Cancer Genetics Show details All news & events Further Breakthrough Device Designation from the FDA – now also for blood test to diagnose inaccessible brain tumours Show details All news & events RENOWNED ASSIGNMENT TO THE SCIENTIFIC ADVISORY BOARD OF DATAR CANCER GENETICS Show details All news & events PROMISING INITIAL STUDY RESULTS IN THE DETECTION OF GLIAL MALIGNANCIES USING GLIAL CELLS IN THE BLOOD Show details All news & events HOT NEWS! OUR LATEST PUBLICATION IN FRONTIERS IN MEDICINE Show details All news & events MARKET ENTRY IN THE USA THANKS TO AGREEMENT WITH ARTEMIS DNA Show details All news & events Screeening test for the early detection of prostate cancer also receives “Breakthrough Device Designation” from the FDA Show details All news & events US FDA grants ‘Breakthrough Designation’ for our blood test used for early detection of breast cancer Show details All news & events MKOT – Precision Oncology Symposium Sept. 2021 Show details All news & events DCG expands Product Portfolio to Screening-Test Show details All news & events Our cooperation with Iylon Precision Oncology Show details All news & events
